Arteriosclerosis disorder
MONDO:0002277A vascular disorder characterized by thickening and hardening of the walls of the arteries.
Also known as: arterial sclerosis, arteriosclerosis, arteriosclerotic cardiovascular disease, vascular sclerosis
548 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Gum treatment may boost artery function in periodontitis patients
Disease control CompletedThis trial investigates whether non-surgical gum treatment can improve early signs of blood vessel dysfunction in people with periodontitis who have no known heart disease. Sixty participants will receive one of two types of deep cleaning procedures. Researchers will measure chan…
Phase: NA • Sponsor: University of Catania • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Pharmacist phone calls could boost lifesaving statin use in heart patients
Disease control CompletedThis study tests whether having a pharmacist call both patients with heart disease and their doctors can increase the use of high-intensity statins—powerful cholesterol-lowering drugs that prevent future heart problems. The trial includes adults aged 18 to 75 with atherosclerotic…
Sponsor: Duke University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a Protein-Rich diet and strength training boost heart recovery?
Disease control CompletedThis study explores whether combining a high-protein Mediterranean diet with resistance exercise can help people with heart disease build muscle and lower their risk of future heart problems. The trial enrolls adults who have completed cardiac rehab and may have low muscle mass w…
Phase: NA • Sponsor: Liverpool John Moores University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Walking your way to better health: smartphone program shows promise for heart and diabetes patients
Disease control CompletedThis study tests whether a three-month smartphone-supported walking program can improve daily step counts, psychological well-being, and body composition in adults with cardiovascular disease or type 2 diabetes. Participants use the Walk15 app to set personalized step goals and t…
Phase: NA • Sponsor: Klaipėda University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New coaching model boosts cardiac rehab use in seniors
Disease control CompletedThis study tested a coaching program called MACRO-I for adults aged 70 and older who had a heart event. The program used coaches to guide patients through starting cardiac rehab, either at a center, at home, or a mix of both. 416 participants were split into the coaching group or…
Phase: NA • Sponsor: Daniel Forman, MD • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Cholesterol-Lowering drug aims to stop first heart attacks
Disease control CompletedThis large study tested whether evolocumab (Repatha), a cholesterol-lowering injection, could reduce major cardiovascular events like heart attacks, strokes, or death in over 12,000 adults at high risk but without a prior heart attack or stroke. Participants received either evolo…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Shock to the system: EMS may supercharge workouts for menopausal women
Disease control CompletedThis study looks at whether adding lower-body electrical muscle stimulation (EMS) to resistance training helps postmenopausal women more than exercise alone. After menopause, women face higher risks of muscle loss and stiff arteries. The trial will compare three groups: EMS plus …
Phase: NA • Sponsor: Seoul National University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New artery surgery shows promise for leg pain
Disease control CompletedThis study tested a surgical technique called femoral tripod eversion for people with blocked leg arteries. 37 patients were followed for two years to check safety and effectiveness. The procedure aims to clear blockages without using synthetic materials. Early results suggest it…
Sponsor: Hôpital NOVO • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New blood thinner may shield heart during artery procedure
Disease control CompletedThis study tested whether ticagrelor, a newer antiplatelet drug, reduces heart muscle damage during a procedure called rotational atherectomy, which clears hardened arteries. 180 stable heart patients received either ticagrelor or standard clopidogrel before and after the procedu…
Phase: PHASE4 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug targets hidden heart risk in black and hispanic communities
Disease control CompletedThis study tested a drug called pelacarsen in 422 Black/African American and Hispanic patients with high Lp(a) levels and existing heart disease. Lp(a) is a genetic risk factor for heart attacks and strokes. The goal was to see if pelacarsen could safely lower Lp(a) levels over 1…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a bone marrow stimulant help people with leg artery disease walk farther?
Disease control CompletedThis study tested whether a drug called GM-CSF can improve symptoms and blood flow in people with peripheral artery disease (PAD), a condition where plaque narrows leg arteries, causing pain and limiting walking. 151 participants received either GM-CSF or a placebo for two 3-week…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Laser catheter shows promise for unclogging leg arteries
Disease control CompletedThis study looked at how well the AURYON atherectomy device works for people with peripheral artery disease (PAD), where leg arteries become blocked. The device uses a laser to vaporize plaque and restore blood flow. Researchers followed 102 patients to see if the procedure was s…
Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug combo after stroke shows promise in preventing early decline
Disease control CompletedThis study tested whether giving a powerful cholesterol-lowering drug (evolocumab) within 6 hours after a stroke procedure (thrombectomy) could prevent early neurological worsening. 60 adults with large-vessel stroke were randomly assigned to receive either the drug plus standard…
Phase: PHASE4 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Can a gout drug cool down artery inflammation in diabetics?
Disease control CompletedThis study tested whether colchicine, a drug used for gout, can reduce inflammation in the arteries of people with diabetes who recently had a heart attack or stroke. Researchers used a special PET scan to measure inflammation in the blood vessels. 115 participants were randomly …
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Heart showdown: which diabetes drug wins?
Disease control CompletedThis completed study looked at two diabetes drugs, tirzepatide and sitagliptin, to see which one better prevents heart attacks, strokes, or death in people with type 2 diabetes and heart disease. Researchers analyzed data from over 49,000 patients. The goal was to learn how well …
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Exercise may protect postmenopausal Women's arteries
Disease control CompletedThis study looked at whether different types of exercise—aerobic, resistance, or a mix—can reduce the risk of hardening of the arteries in postmenopausal women who don't exercise. 113 women participated, and researchers measured changes in blood vessel health and blood pressure. …
Phase: NA • Sponsor: Beijing Sport University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New shot shows promise for stubborn high fats in blood
Disease control CompletedThis study tested a drug called olezarsen in 154 adults with high triglycerides (a type of blood fat) and either heart disease or very high triglycerides. Participants received injections of the drug or a placebo for up to 12 months. The main goal was to see if the drug could low…
Phase: PHASE2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New daily pill could rival insulin for diabetes and heart risk
Disease control CompletedThis study tested a once-daily pill called orforglipron against insulin glargine in nearly 2,750 adults with type 2 diabetes, obesity or overweight, and increased cardiovascular risk. The main goal was to see if orforglipron could reduce major heart events like heart attacks or s…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New hope for tough-to-treat stroke? tirofiban tested in 516 patients
Disease control CompletedThis study tested whether a powerful blood thinner called tirofiban can improve recovery in people with a specific type of stroke called branch atheromatous disease (BAD). BAD strokes often get worse quickly and have few good treatments. The trial enrolled 516 adults within 48 ho…
Phase: PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Digital program aims to slash heart disease risk by lowering cholesterol
Disease control CompletedThis study tested a digital quality improvement program to help doctors better manage LDL (bad) cholesterol in patients with heart disease. Over 1,400 adults with established cardiovascular disease participated. The program used smartphone tools to improve treatment and follow gu…
Phase: NA • Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a diabetes drug also protect the heart? new study tests liraglutide
Disease control CompletedThis study screened 316 people with type 2 diabetes who were at high risk for heart disease. Researchers tested whether adding the drug liraglutide to standard care could reduce new heart problems like heart attacks, strokes, and hospitalizations. The goal was to see if this appr…
Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Is surgery better than watching for seniors with high calcium?
Disease control CompletedThis study looked at whether surgery helps people over 65 with mild primary hyperparathyroidism (high calcium levels) compared to just monitoring them. The goal was to see if surgery improves bone density and lowers fracture risk. A total of 102 participants were randomly assigne…
Phase: NA • Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New catheter delivers drug directly to leg arteries to prevent reblockage
Disease control CompletedThis pilot study tested whether delivering the drug paclitaxel directly to the leg artery during angioplasty could reduce the chance of the artery narrowing again. 27 adults with leg pain from blocked arteries took part. The main goal was to see if the drug helped keep the artery…
Phase: NA • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a common gout drug help unclog leg arteries?
Disease control CompletedThis study tested whether colchicine, a drug used for gout, can reduce inflammation in the leg arteries of people with peripheral artery disease (PAD). Twenty-four adults with PAD received either colchicine or a placebo. Researchers used special scans and blood tests to measure c…
Phase: EARLY_PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New stent shows promise for blocked brain arteries
Disease control CompletedThis study tested a special stent designed to open severely narrowed brain arteries in 194 people with symptomatic intracranial atherosclerosis. The goal was to see if the stent is safe and effective at keeping arteries open for at least 12 months. Researchers measured how often …
Phase: NA • Sponsor: Medos International SARL • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New shot slashes hidden heart risk in phase 2 trial
Disease control CompletedThis phase 2 trial tested olpasiran, an injectable drug, in 281 adults with high lipoprotein(a) – a genetic risk factor for heart disease. Participants received either olpasiran or a placebo. The main goal was to see how much the drug lowered Lp(a) levels after 36 weeks. Results …
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New stent helps people with leg artery disease walk better and feel better
Disease control CompletedThis study looked at how well the ELUVIA drug-coated stent works in real-world patients with blocked arteries in the thigh or knee area. A total of 291 adults received the stent and were followed for two years. The main goal was to see if their quality of life and walking ability…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Heart attack patients: can a common gout pill improve bypass recovery?
Disease control CompletedThis study tested whether the anti-inflammatory drug colchicine can reduce complications like irregular heartbeat, heart sac inflammation, and heart damage after coronary artery bypass surgery. 100 patients who had a recent heart attack and needed bypass surgery were randomly ass…
Phase: PHASE2 • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Heart stent passes Real-World test: orsiro keeps arteries open
Disease control CompletedThis study looked at 556 people with coronary artery disease to confirm that the Orsiro drug-eluting stent is safe and effective in everyday use. The stent releases sirolimus to prevent artery re-narrowing. Researchers tracked how many patients had heart-related death, heart atta…
Sponsor: Biotronik, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New drug AZD0780 aims to lower blood pressure in heart patients
Disease control CompletedThis study tested a new drug called AZD0780 in 202 people with heart disease or related risks and high LDL cholesterol. Participants took either the drug or a placebo for 4 weeks, and researchers measured changes in blood pressure using a 24-hour monitor. The goal was to see if A…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Deep clean teeth to tame heart disease and diabetes?
Disease control CompletedThis study tested whether intensive dental cleaning and oral hygiene advice can improve gum health and also affect markers of heart disease and type 2 diabetes. About 200 adults with gum disease and either heart disease or diabetes (or prediabetes) took part. Researchers measured…
Phase: PHASE4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug aims to lower dangerous fat levels in the blood
Disease control CompletedThis Phase 3 study tested a drug called olezarsen in 1,478 people with very high triglycerides (a type of blood fat) and either heart disease or a high risk for it. Participants received either olezarsen or a placebo as a shot under the skin. The main goal was to see if olezarsen…
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Blood filtering shows promise for high lipoprotein(a) in dialysis patients
Disease control CompletedThis small completed study looked at a blood filtering procedure called double-filtration plasmapheresis (DFPP) in 5 kidney dialysis patients with very high levels of lipoprotein(a), a fatty substance linked to heart disease and blood clots. The goal was to see if DFPP could lowe…
Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Massive study reveals Semaglutide's Heart-Protective power in obesity
Disease control CompletedThis study looked at whether a once-weekly medicine called semaglutide (used for weight loss and diabetes) can lower the risk of heart attacks, strokes, and death in people with overweight or obesity. Researchers analyzed medical records of over 285,000 people in the US. The goal…
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Heart artery showdown: shockwave or cutting balloon before stenting?
Disease control CompletedThis study tested two methods to prepare hardened (calcified) heart arteries before placing a stent: a cutting balloon and a shockwave device. About 413 adults with moderate to severe artery hardening took part. The goal was to see which method helps the stent fit better and work…
Phase: NA • Sponsor: Baim Institute for Clinical Research • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New injection challenges pill in battle against high cholesterol
Disease control CompletedThis study tested whether a twice-yearly injection (inclisiran) lowers LDL cholesterol better than a daily pill (bempedoic acid) in 402 adults with heart disease who still have high cholesterol despite taking statins. Participants received either inclisiran or bempedoic acid on t…
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New combo therapy may stop stroke from getting worse
Disease control CompletedThis study tested whether adding a fast-acting blood thinner (tirofiban) to standard aspirin can prevent strokes from getting worse in people with small artery blockages in the brain. About 970 adults aged 18-80 who had a mild stroke within the last 48 hours took part. The goal w…
Phase: PHASE4 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New balloon device shows promise in clearing hardened heart blockages
Disease control CompletedThis study tested a very small balloon catheter (Sapphire 3) in 170 people with severely blocked heart arteries (chronic total occlusions). The balloon was used to open the blockage before placing a stent. The main goal was to see if the device could be safely delivered, inflated…
Phase: NA • Sponsor: OrbusNeich • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug shows promise for lowering bad cholesterol without statins
Disease control CompletedThis study tested a drug called inclisiran in 207 Chinese adults with moderately high bad cholesterol (LDL-C) who were not taking other cholesterol medicines. Participants received either inclisiran or a placebo for 6 months, followed by 6 months where everyone got the drug. The …
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
HIV heart risk targeted: new drug shows promise in reducing arterial inflammation
Disease control CompletedThis study tested whether a drug called alirocumab, which lowers cholesterol, can reduce heart disease risk in people with HIV. The trial involved 118 adults aged 40 and older with well-controlled HIV and high heart disease risk. Participants received either alirocumab or a place…
Phase: PHASE3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Two cholesterol drugs better than one? new study investigates
Disease control CompletedThis completed trial looked at whether taking two cholesterol-lowering drugs (rosuvastatin and ezetimibe) is more effective and safer than taking just one (rosuvastatin) for people with heart disease. 66 adults with high cholesterol were randomly assigned to one of the two treatm…
Phase: PHASE2, PHASE3 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can a natural supplement boost heart drug benefits in older women?
Disease control CompletedThis completed study looked at 60 postmenopausal women with stable coronary artery disease. Researchers tested whether adding a daily 1000 mg quercetin supplement to standard atorvastatin treatment could affect levels of estrogen and a protein called SIRT1, which are linked to he…
Phase: NA • Sponsor: InCor Heart Institute • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New wire device aims to unclog leg arteries without surgery
Disease control CompletedThis early study tested a new tool called the FastWire System in 8 people with severely blocked leg arteries. The goal was to see if the device could safely cross the blockage and allow doctors to place other treatments to restore blood flow. The study focused on safety and wheth…
Phase: NA • Sponsor: Versono Medical Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Heart patients get Double-Duty blood thinners in massive trial
Disease control CompletedThis completed trial tested whether taking two blood thinners (clopidogrel and aspirin) for 12 months after a heart stent procedure is better than aspirin alone for people with multiple blocked coronary arteries. Over 8,000 patients were enrolled across 100 centers. The main goal…
Phase: PHASE4 • Sponsor: Harbin Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug targets inflammation in heart and kidney patients
Disease control CompletedThis early-stage trial tested a new drug called AZD4144 in 29 people who have both heart disease and chronic kidney disease. The main goal was to see if the drug is safe and if it lowers certain markers of inflammation in the blood. The study compared the drug against a placebo o…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Flu vaccine may tame heart inflammation, small study hints
Disease control CompletedThis study looked at whether the flu vaccine can reduce inflammation in people with stable coronary artery disease. Inflammation plays a key role in heart disease progression. The trial involved 47 adults aged 60 and older with stable heart disease, who received the flu vaccine e…
Phase: PHASE4 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Heart study tests if lowering 'Bad' cholesterol even more saves lives
Disease control CompletedThis study looked at 3048 adults with heart or blood vessel disease to see if lowering LDL ('bad') cholesterol to a very low level (below 55 mg/dL) is better than the standard target (below 70 mg/dL). Participants received either a statin alone or a statin plus ezetimibe. The goa…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New balloon method may improve stent success in Rock-Hard arteries
Disease control CompletedThis study tested whether a special balloon that uses sound waves to break up calcium (balloon lithoplasty) works better than standard balloons for preparing severely calcified coronary arteries before placing a stent. The trial involved 200 adults with stable heart disease or no…
Phase: NA • Sponsor: Herlev and Gentofte Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
VA nurses take on heart disease in HIV-positive veterans
Disease control CompletedThis study tested whether a nurse-led program could help veterans with HIV lower their blood pressure and reduce their risk of heart disease. 305 veterans with HIV and high blood pressure took part. The program used video visits and care coordination to help manage blood pressure…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug inclisiran aims to slash cholesterol after heart attacks
Disease control CompletedThis study tested whether adding a drug called inclisiran to standard care helps lower 'bad' LDL cholesterol more effectively in people who recently had a heart attack. About 400 participants received either the new care pathway including inclisiran or usual care alone. The goal …
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New daily pill aims to crush stubborn cholesterol in High-Risk patients
Disease control CompletedThis Phase 3 trial tested a daily pill combining two drugs, obicetrapib and ezetimibe, in 407 people with inherited high cholesterol or heart disease. Participants took the combination or a placebo on top of their usual cholesterol meds. The main goal was to see if the combo lowe…
Phase: PHASE3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New obesity drug AZD4144 enters human testing
Disease control CompletedThis early-stage study tested a new drug called AZD4144 in 28 adults with obesity to see if it is safe and how it affects inflammation markers in the blood. Participants took either the drug or a placebo daily for a short time. The goal was to check for side effects and measure c…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Prostate pills may shield heart, huge study hints
Disease control CompletedThis completed study looked at medical records from over 10,000 men with enlarged prostate (BPH) in the UK and China. Researchers wanted to see if men taking 5-alpha reductase inhibitors (drugs like finasteride) had fewer heart problems like heart attacks and strokes. The study c…
Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Stem cells injected before amputation aim to prevent further surgery
Disease control CompletedThis study tested whether injecting donor stem cells into the leg muscles before amputation could prevent wound problems and reduce the need for more amputations. 81 people scheduled for leg amputation due to poor blood flow took part. The main goal was to check safety, not yet t…
Phase: PHASE1 • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New pill could help lower stubborn high cholesterol
Disease control CompletedThis study tested a new drug called obicetrapib in over 2,500 people with high cholesterol that wasn't well controlled by their current treatments. Participants took either a 10 mg obicetrapib pill or a placebo daily for about 6 months. The main goal was to see if obicetrapib cou…
Phase: PHASE3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated Jun 26, 2026 18:50 UTC
-
Cholesterol combo pill shows promise for High-Risk hearts
Disease control CompletedThis study tested whether adding ezetimibe to atorvastatin (a common cholesterol drug) works better than atorvastatin alone in people at very high risk for heart attacks or strokes. Researchers enrolled 137 adults with atherosclerotic cardiovascular disease and measured how much …
Phase: PHASE4 • Sponsor: Organon and Co • Aim: Disease control
Last updated Jun 26, 2026 15:09 UTC
-
New device could make measuring heart health in kids easier
Diagnosis CompletedThis study tests whether a simpler device called pOpmètre can accurately measure arterial stiffness in children aged 4 to 8. Arterial stiffness is an important sign of heart and blood vessel health. The standard device, Sphygmocor, is harder to use in children. If pOpmètre works …
Phase: NA • Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Eye scans may reveal hidden heart risks
Diagnosis CompletedThis study looked at whether a special eye scan (SS-OCTA) can detect signs of cardiovascular disease. Researchers compared retinal blood vessel changes to results from a standard carotid ultrasound in 42 adults. The goal was to see if the eye scan could predict the presence or se…
Sponsor: Northwestern University • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Can a CT scan replace PET for heart disease diagnosis?
Diagnosis CompletedThis study compared two types of heart scans—CT and PET—to see if CT can measure blood flow to the heart as accurately as PET, which is the current gold standard. Researchers enrolled 20 adults with suspected coronary artery disease. Each participant received both a CT scan and a…
Phase: NA • Sponsor: Emory University • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Clean stoves for pregnant women may prevent low birth weight and pneumonia
Prevention CompletedThis study tested whether giving pregnant women in India, Guatemala, Peru, and Rwanda a clean-burning liquefied petroleum gas (LPG) stove and free fuel for 18 months could improve health outcomes for their babies. Over 3,600 households participated, with half receiving the LPG st…
Phase: NA • Sponsor: Emory University • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
Two or three workouts a week? study finds best exercise dose for seniors at risk
Prevention CompletedThis study looked at how often older adults with heart disease risk factors should exercise to improve fitness and blood pressure. Twenty-two participants did combined training either twice or three times a week for 12 weeks. The goal was to see which frequency worked better for …
Phase: NA • Sponsor: Universidade Federal de Santa Catarina • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Wisconsin tribe tests coaching to slash stroke risk
Prevention CompletedThis study tested whether intensive, face-to-face coaching on lifestyle changes and medication adherence could reduce strokes and mini-strokes in 120 high-risk Native American adults in Wisconsin. Participants received either intensive coaching or standard care, with regular heal…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Prevention
Last updated Jun 27, 2026 08:05 UTC
-
Phone-based peer program aims to slash heart risk in low-income groups
Prevention CompletedThis study tested an 8-week digital lifestyle program called MYCardio-PEER for low-income adults at risk of heart disease. Participants received weekly videos and infographics on healthy eating and exercise, plus group chats with peer leaders. The goal was to see if the program i…
Phase: NA • Sponsor: Monash University Malaysia • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
Heart-Healthy women: exercise and brain games may ward off memory loss
Prevention CompletedThis study looked at whether a home-based physical activity program and computer-based cognitive training could help prevent memory loss in older women with heart disease. 253 women aged 65 and older participated. The goal was to see if these lifestyle changes could improve memor…
Phase: NA • Sponsor: Rush University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Digital nudges boost flu vaccine uptake in High-Risk adults
Prevention CompletedThis completed study tested whether sending behavioral nudges through Denmark's official electronic letter system could increase flu vaccination among adults aged 18-64 with chronic diseases. Over 300,000 participants were randomly assigned to receive different types of letters o…
Phase: NA • Sponsor: Tor Biering-Sørensen • Aim: Prevention
Last updated Jun 26, 2026 15:51 UTC
-
Saliva test reveals best pain relief for Open-Heart patients
Symptom relief CompletedThis study looked at two methods to reduce pain after heart surgery through a cut in the chest bone. 120 adults received either a nerve block near the breastbone, pain medicine injected into the wound, or standard painkillers. Researchers measured pain levels using a saliva test …
Phase: NA • Sponsor: Ataturk University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Couples therapy for heart patients? new program aims to heal hearts together
Symptom relief CompletedThis completed trial tested an 8-week program called Healing Hearts Together (HHT) for couples where one partner has heart disease. 474 couples attended weekly group sessions focused on communication, emotional support, and heart health. The goal was to see if the program improve…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Watching videos before surgery may ease nerves, study finds
Symptom relief CompletedThis study tested whether giving vascular surgery patients access to a website with educational videos could reduce their anxiety before the operation. 250 patients were split into two groups: one got the videos, the other did not. Researchers measured anxiety using a simple 0-to…
Phase: NA • Sponsor: Centre Chirurgical Marie Lannelongue • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Prayer and relaxation calm heart surgery patients, study finds
Symptom relief CompletedThis study tested whether a 20-minute session of nurse-led spiritual care, including prayer and relaxation techniques, could help heart surgery patients feel less anxious and have more stable blood pressure and heart rate before their operation. 248 adults in Indonesia took part.…
Phase: NA • Sponsor: Lincoln University College Malaysia • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Yoga boosts heart recovery in seniors, pilot finds
Symptom relief CompletedThis study tested whether a 3-month yoga program could improve physical and mental health in adults over 65 who had recently finished cardiac rehab. Participants attended yoga twice a week. Researchers measured balance, muscle strength, anxiety, and mood. The goal was to see if y…
Phase: NA • Sponsor: Geunyeong Cha • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Can a heart pill help you walk longer without pain?
Symptom relief CompletedThis study tested whether ramipril, a common blood pressure medicine, can improve walking distance in people with intermittent claudication (leg pain due to narrowed arteries). Researchers planned to enroll 78 adults with stable leg pain, giving half ramipril and half a placebo. …
Phase: PHASE4 • Sponsor: Hull University Teaching Hospitals NHS Trust • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Heart patients find relief with online therapy program
Symptom relief CompletedThis study tested a 9-week internet-based cognitive behavioral therapy (CBT) program designed to reduce stress, anxiety, and depression in people with stable heart disease. 215 adults with heart disease and elevated stress or mood symptoms took part. The program was personalized …
Phase: NA • Sponsor: University Hospital, Linkoeping • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Shock therapy for leg pain? tiny device may help PAD patients move more
Symptom relief CompletedThis study tested whether a small device called TENS, which sends mild electrical pulses to the skin, could reduce leg pain during walking in people with peripheral artery disease (PAD). It also looked at adding a patient education program to encourage more physical activity. The…
Phase: NA • Sponsor: Glasgow Caledonian University • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Virtual reality boosts mood in heart rehab, study finds
Symptom relief CompletedThis study tested whether adding virtual reality (VR) driving simulations to standard cardiac rehabilitation helps heart surgery patients feel less anxious and depressed. Sixty adults recovering from heart surgery took part. The results suggest VR can improve emotional well-being…
Phase: NA • Sponsor: I.R.C.C.S. Fondazione Santa Lucia • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Rare cholesterol disease study aims to detect heart risks early
Knowledge-focused CompletedThis study looks at people with a rare inherited condition that causes extremely high cholesterol and early heart disease. Researchers used special tests to measure artery hardening before it becomes life-threatening. The goal was to gather information to help develop future trea…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Family secrets? study maps how relatives talk about genetic health risks
Knowledge-focused CompletedThis study explored how family members share health information about genetic diseases like sickle cell, diabetes, and cancer. Over 1,000 adults completed surveys or interviews about their family health history and support. The goal was to understand social and relational factors…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Gene hunt for rare cholesterol problems
Knowledge-focused CompletedThis study aimed to find new gene changes that cause rare lipid disorders. Researchers used advanced genetic testing to look at many genes at once in 140 people and their relatives. The goal was to discover causes that older methods missed.
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Could a cholesterol drug prevent first heart attacks in High-Risk patients?
Knowledge-focused CompletedThis completed study observed over 4,500 adults with atherosclerotic cardiovascular disease who had never had a heart attack or stroke. Researchers compared those taking alirocumab (a cholesterol-lowering drug) to those not on similar therapy, using real-world data to see if the …
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple gas protect organs during surgery?
Knowledge-focused CompletedThis pilot study tested whether giving inhaled nitric oxide gas during laparoscopic surgery could protect blood vessels and organs in 40 adults with heart disease. Half received the gas through their breathing tube during surgery, and half received standard care. Researchers meas…
Phase: NA • Sponsor: Alexander Averyanov • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
New X-Ray tool could spot dangerous heart calcium faster
Knowledge-focused CompletedThis study tested a new X-ray-based imaging tool called 3DStent against the standard IVUS method to measure calcium buildup in heart arteries. Thirty adults with coronary lesions were enrolled. The goal was to see if 3DStent can accurately identify and measure calcium deposits, w…
Phase: NA • Sponsor: RCF@ICPS • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Diabetes Drug's hidden effect on heart fat revealed
Knowledge-focused CompletedThis study looked at how a diabetes medicine called ertugliflozin affects fat tissue around the heart. Researchers took fat samples from 61 adults with type 2 diabetes and heart disease during heart surgery. They tested the fat in a lab to see if the drug improved how the fat cel…
Phase: EARLY_PHASE1 • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Can your genes predict blood thinner success? new study targets caribbean hispanics
Knowledge-focused CompletedThis study looked at 150 Caribbean Hispanic adults with heart disease or stroke risk who take the blood thinner clopidogrel. Researchers wanted to see if certain gene variants affect how well the drug works. The goal is to understand why some people get less benefit and to pave t…
Phase: EARLY_PHASE1 • Sponsor: University of Puerto Rico • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Many heart patients skip their meds, study finds
Knowledge-focused CompletedThis study checked how well over 5,000 heart patients follow their prescribed medicine routine. Researchers asked patients about their medication habits and any side effects. The goal was to understand how many patients do not take their medicines as directed.
Sponsor: National Medical Research Center for Therapy and Preventive Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Massive study pits tirzepatide against rivals for heart protection
Knowledge-focused CompletedThis completed study looked at insurance claims data from 70,000 people with type 2 diabetes and established heart disease to compare the heart-related risks of three diabetes drugs: tirzepatide, dulaglutide, and semaglutide. The goal was to see if any of these drugs was linked t…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Blood clues may predict heart trouble after stent
Knowledge-focused CompletedThis study checked if certain blood markers can predict serious heart events like heart attack or death within a year after a stent procedure. Researchers measured two types of cells related to blood vessel health in 170 adults scheduled for a stent. The goal was to see if these …
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can a cholesterol drug tame inflammation in diabetes? small study investigates
Knowledge-focused CompletedThis completed Phase 4 trial looked at how evolocumab (Repatha), a cholesterol-lowering drug, affects markers of inflammation and blood clotting in 41 people with type 2 diabetes and heart disease. Participants received either evolocumab or a placebo injection every 4 weeks for 1…
Phase: PHASE4 • Sponsor: Robert Rosenson • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Can a doctor's referral to an exercise coach get people moving?
Knowledge-focused CompletedThis study tested a program where doctors refer inactive people with chronic diseases (like diabetes, heart disease, or obesity) to an exercise professional for personalized counseling. The goal was to see if this referral scheme helps people become more active compared to just g…
Phase: NA • Sponsor: University of Erlangen-Nürnberg • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Heart CT radiation under the microscope: new registry tracks exposure
Knowledge-focused CompletedThis completed study looked at how much radiation people receive during heart CT scans (CCTA) in everyday hospital practice. Researchers enrolled 66 adults who needed a heart CT and recorded the radiation dose used, along with any dose-saving techniques. The goal was to understan…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Heart scan surprise: does a simple notification boost lifesaving treatment?
Knowledge-focused CompletedThis study looked at 233 people with heart or blood vessel disease who had calcium buildup in their heart arteries found by chance on a chest CT scan. Researchers wanted to see if telling both the patient and their doctor about this finding would encourage them to start cholester…
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New cholesterol drug inclisiran tested in everyday clinics
Knowledge-focused CompletedThis completed study followed 1868 patients with high cholesterol to see how inclisiran (Leqvio®) and other cholesterol-lowering treatments work in real-world medical practice. Researchers tracked heart events, medication use, and lab results without assigning any treatments. The…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New turkish tool aims to spot depression in heart patients
Knowledge-focused CompletedThis study checked whether the Turkish version of the Cardiac Depression Scale (CDS) works well for people with heart disease. Researchers tested 360 Turkish adults with various heart conditions to see if the scale accurately measures depression. The goal is to give doctors a rel…
Sponsor: Kırıkkale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Arm workouts may boost leg oxygen in PAD patients, study finds
Knowledge-focused CompletedThis study looked at 26 people with peripheral arterial disease (PAD) to see how arm exercise changes oxygen levels in their leg muscles. Participants used an arm ergometer while a sensor measured calf oxygen saturation. The goal was to understand why arm training can improve leg…
Sponsor: University of Nove de Julho • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Heart and mind: new study explores the hidden links between cardiovascular disease and mental illness
Knowledge-focused CompletedThis completed study looked at 400 people with both heart disease and a mental health condition (like depression or anxiety). Researchers used questionnaires, blood tests, and imaging to find shared risk factors and biological markers. The goal was to better understand how these …
Sponsor: Ningbo No. 1 Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Cancer drug heart risk mystery probed in new study
Knowledge-focused CompletedThis study looked at how immune checkpoint inhibitors, a type of cancer drug, might affect blood vessels and increase heart risks. Researchers measured blood vessel function and checked for related markers in 39 cancer patients before and after starting treatment. The goal was to…
Phase: NA • Sponsor: Institut Mutualiste Montsouris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New MRI technique could help predict strokes in High-Risk patients
Knowledge-focused CompletedThis study tested a new MRI method to better predict stroke risk in people with intracranial atherosclerosis, a condition where arteries in the brain become narrowed. Researchers measured how well different parts of the brain responded to changes in blood flow. The goal was to fi…
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Hidden bacteria in artery plaques may predict Post-Surgery risks
Knowledge-focused CompletedThis study examined 200 adults who had surgery to remove plaque from their carotid arteries. Researchers identified bacteria living inside the plaques and tracked whether certain types were linked to later strokes, re-narrowing of the artery, or death. The goal was to learn which…
Sponsor: Tang-Du Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Fitbit for the heart: tiny tracker may speed recovery after surgery
Knowledge-focused CompletedThis study looked at whether wearing an activity monitor (like a Fitbit) after heart surgery helps patients get moving sooner and return to their normal activity levels faster. Researchers tracked motivation, length of hospital stay, and readmission rates in 12 adults who had car…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Scientists dig into Cholesterol's hidden secrets to fight heart disease
Knowledge-focused CompletedThis study looked at 86 people with very high or very low cholesterol efflux—a measure of how well the body removes cholesterol from cells. Researchers analyzed their genes, proteins, and lipids to find clues that could lead to new ways to prevent or reverse heart disease. The go…
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:04 UTC
-
Talking less meds: training helps doctors cut pills for seniors
Knowledge-focused CompletedThis study tested whether special communication training for pharmacists and general practitioners helps them involve older patients in decisions to stop or lower medications for heart disease and diabetes. Researchers enrolled 310 patients aged 75 and older who were taking certa…
Phase: NA • Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Scientists uncover clue to leg artery disease in MicroRNA
Knowledge-focused CompletedThis study looked at a molecule called microRNA-210 in 230 people with peripheral artery disease (PAD), a condition where leg arteries become blocked. Researchers measured its levels and linked them to oxidative stress and walking ability. The goal was to understand how this mole…
Phase: NA • Sponsor: University of West Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Motivational letter may boost heart rehab Follow-Up attendance
Knowledge-focused CompletedThis study tested whether a theory-based motivational letter mailed six months in advance could increase attendance at a one-year post-cardiac rehabilitation check-up. Researchers compared 102 adults who received the letter to those who got usual care. The goal was to see if a si…
Phase: NA • Sponsor: University of Calgary • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Heart scan surprise: notifying patients boosts statin use
Knowledge-focused CompletedThis study looked at whether notifying patients and their doctors about calcium found in the heart arteries on a routine chest CT scan would lead to more people starting statin medications. Researchers enrolled 202 adults who had this incidental finding and randomly assigned them…
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Even on blood thinners, strokes happen – study investigates why
Knowledge-focused CompletedThis study looked at 91 Chinese patients with atrial fibrillation who had a stroke while taking blood thinners (NOACs). The goal was to understand why these strokes happen and whether not taking the medication as prescribed played a role. Researchers hope this knowledge will help…
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Gut bacteria may hold clues to stroke recovery
Knowledge-focused CompletedThis study looked at 120 people who had an acute ischemic stroke to see if the types of bacteria in their gut were linked to how well they recovered. Researchers analyzed stool samples and brain scans, and tracked disability over 6 months. The goal was to understand the role of g…
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Doctors polled on inflammation blood test for heart and kidney patients
Knowledge-focused CompletedThis study surveyed 608 heart and kidney doctors to understand their awareness and use of a blood test called hsCRP, which measures inflammation. The goal was to learn what doctors think about inflammation's role in treating patients with heart disease, kidney disease, or heart f…
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Gum treatment may reveal gender differences in immune response
Knowledge-focused CompletedThis study looked at 100 people with gum disease, some also with obesity, to see how non-surgical gum cleaning affects the body's immune system. Researchers measured changes in inflammation and immune cells before and after treatment, comparing men and women. The goal was to find…
Sponsor: Milagros Rocha Barajas • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Which carotid surgery technique is safer? new study reveals early results
Knowledge-focused CompletedThis study looked at 129 patients who had surgery to clear blocked neck arteries, a common cause of stroke. Doctors compared two surgical techniques—the eversion method and the conventional method—to see which had fewer complications like stroke or artery re-blockage within 30 da…
Sponsor: Kastamonu University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Tiny study asks: does aspirin work in patients with low platelets?
Knowledge-focused CompletedThis study looked at how well a daily low-dose aspirin works in people who have both immune thrombocytopenia (low platelets) and heart disease. Only 4 adults took part. Researchers measured platelet function after aspirin to see if the standard dose is enough to prevent blood clo…
Phase: PHASE2 • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Did a simple phone call keep chronic patients out of the hospital?
Knowledge-focused CompletedThis study tested whether a systematic phone call from a medical student, supervised by a general practitioner, could reduce hospitalizations in patients with chronic heart or mental health conditions during the COVID-19 lockdown in France. Over 22,000 patients aged 70 and older …
Phase: NA • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Which risk score best predicts heart surgery survival?
Knowledge-focused CompletedThis study looked at 320 adults who had heart surgery to see how well two different risk scores (EuroSCORE-II and POSPOM) predict the chance of dying in the hospital. Researchers calculated each patient's scores before surgery and compared them to what actually happened. The goal…
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New tool helps patients and therapists make better choices for leg pain
Knowledge-focused CompletedThis study tested a tool called KomPas+ that helps therapists and patients with leg pain from blocked arteries (intermittent claudication) make shared decisions about treatment. Over 2,200 participants used the tool to see if it improved walking distance and quality of life. The …
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Scientists investigate why high 'Bad' cholesterol harms heart repair cells
Knowledge-focused CompletedThis completed study examined blood samples from 40 adults to see if high levels of lipoprotein (a), a type of cholesterol, are linked to fewer or different blood vessel repair cells. Participants with high Lp(a) were compared to those with normal levels. The goal was to better u…
Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Heart patients enjoy orienteering as much as walking in rehab study
Knowledge-focused CompletedThis study looked at whether orienteering (a navigation-based walk) is as good as regular walking for heart rehab. 40 people with stable heart disease took part. Researchers measured heart rate and enjoyment during both activities. The goal was to see if orienteering could be a f…
Sponsor: Fondation Ildys • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New model aims to predict heart attack outcomes
Knowledge-focused CompletedThis study looked at 1,655 people who had a heart attack or unstable angina (acute coronary syndrome) to create a personalized risk model. Researchers used medical tests, genetic information, and other health data to predict who might have worse outcomes or complications from tre…
Sponsor: Central State Medical Academy • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Heart attack aftercare under the microscope: are guidelines being followed?
Knowledge-focused CompletedThis completed study looked at whether patients hospitalized for a heart attack, stroke, or other cardiovascular event received the right medications to prevent future problems. Researchers reviewed records of 129 patients to see if doctors prescribed cholesterol-lowering drugs a…
Sponsor: Consorci Sanitari de l'Alt Penedès i Garraf • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Doctors' views on hidden inflammation in heart and kidney patients surveyed
Knowledge-focused CompletedThis study surveyed 1,500 Chinese heart and kidney specialists to understand their awareness and perceptions of systemic inflammation in patients with both atherosclerotic cardiovascular disease and chronic kidney disease. The goal was to learn how doctors currently identify and …
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Heart Patients' cholesterol battle: new study reveals hidden barriers
Knowledge-focused CompletedThis completed study in Egypt examined 1,000 adults with heart disease to see how many reached their LDL cholesterol targets and what got in the way. Participants provided a fasting lipid profile, and researchers looked for patterns and barriers. The goal is to find better ways t…
Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Heart disease study probes immune cell 'Recycling' in arteries
Knowledge-focused CompletedThis study examined how immune cells change in people with coronary atherosclerosis (hardening of the arteries). Researchers compared blood and heart tissue samples from 61 patients undergoing heart surgery—some with coronary artery disease and some without. The goal was to see i…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Gut check: could your microbiome predict heart disease?
Knowledge-focused CompletedThis study looked at the gut bacteria and bile acids of 80 people — half with coronary artery disease and half healthy. Researchers wanted to see if differences in these gut factors might be linked to heart disease. The goal is to better understand how the gut influences heart he…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Can air purifiers help heart patients? small study tests new approach
Knowledge-focused CompletedThis study tested an indoor air pollution intervention called AIRWISE in 20 adults aged 55 and older with heart disease. Participants received personal air cleaners, a color-changing air quality monitor, and educational materials. The goal was to see if they would use these tools…
Phase: NA • Sponsor: University of Montana • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Can statins or other drugs fix cholesterol problems in autoimmune disease?
Knowledge-focused CompletedThis completed study examined why people with rheumatoid arthritis (RA) and lupus have a higher risk of heart attacks. Researchers collected blood samples from 176 participants and tested how statins and adenosine A2A receptor agonists affected cholesterol balance in cells. The g…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Massive study reveals hidden heart risk in 40,000 patients
Knowledge-focused CompletedThis study looked at nearly 40,000 people with a history of heart disease caused by clogged arteries. The goal was to measure their levels of lipoprotein(a), a fatty substance that can increase heart risk. Researchers wanted to see how these levels vary by age, sex, race, and reg…
Phase: NA • Sponsor: Amgen • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Real-World data mimics heart trial for diabetes drugs
Knowledge-focused CompletedThis completed study tested whether healthcare claims data can predict the results of a major heart trial (SURPASS-CVOT) comparing two diabetes drugs, tirzepatide and dulaglutide. Researchers analyzed records from over 44,000 people with type 2 diabetes and heart disease to see i…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New cholesterol drug could prevent thousands of heart attacks, study suggests
Knowledge-focused CompletedThis study used national health survey data to estimate how many US adults with high cholesterol might be eligible for a new drug called inclisiran. Researchers also calculated how many heart attacks and strokes could be prevented over 10 years if these patients took the drug. Th…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Vitamin d levels checked for clues to heart risk in kidney patients
Knowledge-focused CompletedThis study looked at whether vitamin D levels in the blood are related to early signs of artery hardening (atherosclerosis) in people on dialysis. Researchers measured vitamin D and used ultrasound to check artery thickness in 90 adults with kidney failure. The goal was to see if…
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Fish oil pill may make 'bad' cholesterol less dangerous, study finds
Knowledge-focused CompletedThis study tested whether taking a high-dose fish oil supplement (E-EPA) for one month changes how LDL ('bad' cholesterol) clumps together in 68 healthy adults. Researchers measured blood fats and LDL stickiness before, during, and after the supplement period. The goal was to und…
Phase: NA • Sponsor: Wihuri Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Heart scan study: family history may reveal hidden plaque risk
Knowledge-focused CompletedThis study used cardiac CT scans to compare the amount of high-risk plaque in the coronary arteries of 480 people with and without a family history of coronary artery disease. All participants had no prior heart problems. The goal was to see if those with a family history have mo…
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:07 UTC
-
Belly fat linked to artery plaque in new imaging study
Knowledge-focused CompletedThis completed study looked at 357 healthy adults aged 35-65 to understand how excess belly fat relates to the buildup of fatty plaque in arteries, a key cause of heart attacks. Using MRI and CT scans, researchers measured abdominal fat and artery wall thickness. The goal was to …
Sponsor: Laval University • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:47 UTC
-
New MRI dye could reveal hidden brain artery inflammation
Knowledge-focused CompletedThis study tested whether a special MRI contrast agent called ferumoxytol can detect inflammation in brain arteries of people who recently had a stroke. Researchers compared it to standard gadolinium contrast in 30 participants with narrowed brain arteries. The goal was to see if…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:41 UTC
-
Psoriasis meds may quietly shield arteries, small study hints
Knowledge-focused CompletedThis study checked if newer psoriasis drugs (IL17/23 inhibitors) also improve artery stiffness, a sign of heart disease. Researchers followed 66 people with moderate-to-severe psoriasis for a year, measuring pulse wave velocity (PWV) and other markers. The goal was to see if thes…
Sponsor: National and Kapodistrian University of Athens • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:40 UTC
-
10-Year study reveals clues to how artery disease spreads
Knowledge-focused CompletedThis study followed 320 people with atherosclerosis for 10 years to see how the disease changes over time. Researchers used ultrasound scans and genetic tests to track artery health and predict heart attacks, strokes, and leg problems. The goal was to better understand why athero…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:30 UTC
-
Can asking patients about their needs reduce hospital visits?
Knowledge-focused CompletedThis study looked at two ways to assign care coordinators to older adults (65+) with heart disease or risk factors. One method used patients' own reports of difficulty coordinating care, while the other used usual triggers like hospital discharge. The goal was to see which approa…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:18 UTC
-
Large study aims to predict stroke in silent artery disease
Knowledge-focused CompletedThis completed observational study followed 3,849 people with asymptomatic intracranial atherosclerosis (narrowing of brain arteries) to better understand how the disease progresses and to improve stroke prediction. Participants underwent routine imaging and cognitive tests over …
Sponsor: Xuanwu Hospital, Beijing • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:06 UTC